FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |   Search Term  Advanced Search

Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe

Previous Volume 335:352-355 August 1, 1996 Number 5 Next

	Since this article has no abstract, we have provided an extract of the first 100 words of the full text and any section headings.

	Full Text Purchase this article Add to Personal Archive Add to Citation Manager Notify a Friend E-mail When Cited Related Article by Donaldson, S. S. Related Article by Bhatia, S. PubMed Citation

To the Editor: Bhatia et al. (March 21 issue)¹ make the unwarranted statement that radiation, but not chemotherapy, increases the risk of solid tumors, especially breast tumors, in patients treated for childhood Hodgkin's disease.

In the study cohort, only 8 percent of the patients received chemotherapy alone; 23 percent received radiation alone. The remainder received both, but to compare the risks of treatments, only the patients receiving one or the other are appropriate for the analysis. Only one patient in the group receiving chemotherapy alone had a solid tumor, but since the expected number of cases was less than one, . . . [Full Text of this Article]

References

This article has been cited by other articles:

• Travis, L. B., Hill, D., Dores, G. M., Gospodarowicz, M., van Leeuwen, F. E., Holowaty, E., Glimelius, B., Andersson, M., Pukkala, E., Lynch, C. F., Pee, D., Smith, S. A., Van't Veer, M. B., Joensuu, T., Storm, H., Stovall, M., Boice, J. D. Jr., Gilbert, E., Gail, M. H. (2005). Cumulative Absolute Breast Cancer Risk for Young Women Treated for Hodgkin Lymphoma. JNCI J Natl Cancer Inst 97: 1428-1437 [Abstract] [Full Text]  
• van Leeuwen, F. E., Klokman, W. J., Stovall, M., Dahler, E. C., van't Veer, M. B., Noordijk, E. M., Crommelin, M. A., Aleman, B. M. P., Broeks, A., Gospodarowicz, M., Travis, L. B., Russell, N. S. (2003). Roles of Radiation Dose, Chemotherapy, and Hormonal Factors in Breast Cancer Following Hodgkin's Disease. JNCI J Natl Cancer Inst 95: 971-980 [Abstract] [Full Text]  
• Diller, L., Nancarrow, C. M., Shaffer, K., Matulonis, U., Mauch, P., Neuberg, D., Tarbell, N. J., Litman, H., Garber, J. (2002). Breast Cancer Screening in Women Previously Treated for Hodgkin's Disease: A Prospective Cohort Study. JCO 20: 2085-2091 [Abstract] [Full Text]  
• Behrens, C., Travis, L. B., Wistuba, I. I., Davis, S., Maitra, A., Clarke, E. A., Lynch, C. F., Glimelius, B., Wiklund, T., Tarone, R., Gazdar, A. F. (2000). Molecular Changes in Second Primary Lung and Breast Cancers after Therapy for Hodgkin's Disease. Cancer Epidemiol. Biomarkers Prev. 9: 1027-1035 [Abstract] [Full Text]  
• Green, D. M., Hyland, A., Barcos, M. P., Reynolds, J. A., Lee, R. J., Hall, B. C., Zevon, M. A. (2000). Second Malignant Neoplasms After Treatment for Hodgkin’s Disease in Childhood or Adolescence. JCO 18: 1492-1499 [Abstract] [Full Text]  
• Swerdlow, A. J., Barber, J. A., Hudson, G. V., Cunningham, D., Gupta, R. K., Hancock, B. W., Horwich, A., Lister, T. A., Linch, D. C. (2000). Risk of Second Malignancy After Hodgkin’s Disease in a Collaborative British Cohort: The Relation to Age at Treatment. JCO 18: 498-498 [Abstract] [Full Text]